Proportion attributable to contextual effects in general medicine: a meta-epidemiological study based on Cochrane reviews.


Journal

BMJ evidence-based medicine
ISSN: 2515-4478
Titre abrégé: BMJ Evid Based Med
Pays: England
ID NLM: 101719009

Informations de publication

Date de publication:
02 2023
Historique:
accepted: 24 06 2022
pubmed: 20 7 2022
medline: 24 1 2023
entrez: 19 7 2022
Statut: ppublish

Résumé

Our objectives were to examine the magnitude of the proportion attributable to contextual effects (PCE), which shows what proportion of the treatment arm response can be achieved by the placebo arm across various interventions, and to examine PCE variability by outcome type and condition. We conducted a meta-epidemiological study. We searched the Cochrane Database of Systematic Reviews with the keyword 'placebo' in titles, abstracts and keywords on 1 January 2020. We included reviews that showed statistically significant beneficial effects of the intervention over placebo for the first primary outcome. We performed a random-effects meta-analysis to calculate PCEs based on the pooled result of each included review, grouped by outcome type and condition. The PCE quantifies how much of the observed treatment response can be achieved by the contextual effects. No patient or member of the public was involved in conducting this research. We included 328 out of 3175 Cochrane systematic reviews. The results of meta-analyses showed that PCEs varied greatly depending on outcome type (I The results suggest that much of the observed benefit is not just due to the specific effect of the interventions. The specific effects of interventions may be larger for subjective outcomes than for objective or semiobjective outcomes. However, PCEs were exceptionally variable. When we evaluate the magnitude of PCEs, we should consider each PCE individually, for each condition, intervention and outcome in its context, to assess the importance of an intervention for each specific clinical setting.

Identifiants

pubmed: 35853683
pii: bmjebm-2021-111861
doi: 10.1136/bmjebm-2021-111861
pmc: PMC9887379
doi:

Types de publication

Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-47

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
BMC Med Res Methodol. 2011 Nov 24;11:160
pubmed: 22114982
Ann Rheum Dis. 2016 Nov;75(11):1964-1970
pubmed: 26882927
Evid Based Ment Health. 2019 Nov;22(4):153-160
pubmed: 31563865
J Am Med Assoc. 1955 Dec 24;159(17):1602-6
pubmed: 13271123
Cochrane Database Syst Rev. 2014 Nov 21;(11):CD006640
pubmed: 25414987
BMJ. 2017 Feb 3;356:j463
pubmed: 28159769
N Engl J Med. 2001 May 24;344(21):1594-602
pubmed: 11372012
Ann Intern Med. 2015 Sep 1;163(5):392-3
pubmed: 26215902
Muscle Nerve. 2017 Sep;56(3):358-367
pubmed: 28249354
Neurology. 2015 Feb 24;84(8):794-802
pubmed: 25632091
Oral Dis. 2014 Apr;20(3):e1-6
pubmed: 24164777
Complement Ther Med. 2013 Apr;21(2):102-4
pubmed: 23497811
BMJ Open. 2015 Dec 11;5(12):e009655
pubmed: 26656986
PLoS Med. 2008 Feb;5(2):e45
pubmed: 18303940
Int J Epidemiol. 2012 Jun;41(3):818-27
pubmed: 22461129
Clin Immunol. 2018 Jan;186:82-86
pubmed: 28736278
Psychosom Med. 1999 Mar-Apr;61(2):250-5
pubmed: 10204979
BMJ. 2008 May 3;336(7651):999-1003
pubmed: 18390493
Evid Based Med. 2017 Aug;22(4):139-142
pubmed: 28701372
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003974
pubmed: 20091554
Cochrane Database Syst Rev. 2015 Feb 05;(2):CD010107
pubmed: 25927097
J Clin Epidemiol. 2015 Jan;68(1):52-60
pubmed: 25304503

Auteurs

Yusuke Tsutsumi (Y)

Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan tsutsumi.yusuke.84x@st.kyoto-u.ac.jp.
Department of Emergency Medicine, National Hospital Organization Mito Medical Center, Ibaraki, Japan.

Yasushi Tsujimoto (Y)

Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine/ School of Public Health, Kyoto, Japan.
Department of Nephrology and Dialysis, Kyoritsu Hospital, Kawanishi, Japan.

Aran Tajika (A)

Department of Psychiatry, Kyoto University Hospital, Kyoto, Japan.

Kenji Omae (K)

Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine/ School of Public Health, Kyoto, Japan.
Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, Fukushima, Japan.

Tomoko Fujii (T)

Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Japan.
Intensive Care Unit, Jikei University Hospital, Tokyo, Japan.

Akira Onishi (A)

Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Hyogo, Japan.

Yuki Kataoka (Y)

Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine/ School of Public Health, Kyoto, Japan.
Hospital Care Research Unit/ Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.

Morihiro Katsura (M)

Department of Surgery, Okinawa Chubu Hospital, Okinawa, Japan.

Hisashi Noma (H)

Department of Data Science, The Institute of Statistical Mathematics, Tokyo, Japan.

Ethan Sahker (E)

Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Japan.
Population Health and Policy Research Unit, Medical Education Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Edoardo Giuseppe Ostinelli (EG)

Oxford Health NHS Foundation Trust, Warneford Hospital /Department of Psychiatry, University of Oxford, Oxford, UK.

Toshi A Furukawa (TA)

Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH